Bruce G. Allen Investments’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17K Hold
15
– – ﹤0.01% 793
2026
Q1
$969 Buy
15
+3
+25% +$211 ﹤0.01% 825
2025
Q4
$808 Buy
12
+1
+9% +$67 ﹤0.01% 874
2025
Q3
$807 Hold
11
– – ﹤0.01% 869
2025
Q2
$572 Hold
11
– – ﹤0.01% 928
2025
Q1
$702 Buy
11
+2
+22% +$116 ﹤0.01% 873
2024
Q4
$430 Hold
9
– – ﹤0.01% 981
2024
Q3
$515 Buy
+9
New +$516 ﹤0.01% 951

Other funds holding HALO

Bruce G. Allen Investments's HALO Position: Q2 2026 in Review

Bruce G. Allen Investments held its Halozyme (HALO) position steady in Q2 2026 at 15 shares worth $1.17K. The position accounts for ﹤0.01% of the portfolio, ranked #793.

Bruce G. Allen Investments first reported a position in HALO in Q3 2024 and has held it in 8 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Bruce G. Allen Investments held 15 shares of Halozyme worth $1.17K as of Q2 2026.
  • Bruce G. Allen Investments left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q2 2026, its #793 holding.
  • Bruce G. Allen Investments first reported a position in Halozyme in Q3 2024 and has held it in 8 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.